Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the Inflammasome

Limb-Girdle Muscular Dystrophy Type-2B/2R is caused by mutations in the dysferlin gene (DYSF). This disease has two known pathogenic missense mutations that occur within dysferlin’s C2A domain, namely C2AW52R and C2AV67D. Yet, the etiological rationale to explain the disease linkage for these two mutations is still unclear. In this study, we have presented evidence from biophysical, computational, and immunological experiments which suggest that these missense mutations interfere with dysferlin’s ability to repair cells. The failure of C2AW52R and C2AV67D to initiate membrane repair arises from their propensity to form stable amyloid. The misfolding of the C2A domain caused by either mutation exposes β-strands, which are predicted to nucleate classical amyloid structures. When dysferlin C2A amyloid is formed, it triggers the NLRP3 inflammasome, leading to the secretion of inflammatory cytokines, including IL-1β. The present study suggests that the muscle dysfunction and inflammation evident in Limb-Girdle Muscular Dystrophy types-2B/2R, specifically in cases involving C2AW52R and C2AV67D, as well as other C2 domain mutations with considerable hydrophobic core involvement, may be attributed to this mechanism.

[1]  Roshan J. Thapa,et al.  Patch repair protects cells from the small pore-forming toxin aerolysin , 2022, bioRxiv.

[2]  S. Brichard,et al.  Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy , 2022, Frontiers in Immunology.

[3]  Samrat Moitra,et al.  Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins using Leishmania major. , 2022, Journal of visualized experiments : JoVE.

[4]  B. Everts,et al.  The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle , 2022, Journal of cachexia, sarcopenia and muscle.

[5]  J. Kardos,et al.  BeStSel: webserver for secondary structure and fold prediction for protein CD spectroscopy , 2022, Nucleic Acids Res..

[6]  Robyn Roth,et al.  Membrane repair triggered by cholesterol-dependent cytolysins is activated by mixed lineage kinases and MEK , 2022, Science advances.

[7]  Karra A. Jones,et al.  The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies , 2022, Acta neuropathologica communications.

[8]  R. Sutton,et al.  Redefining the architecture of ferlin proteins: Insights into multi-domain protein structure and function , 2022, bioRxiv.

[9]  L. Guarente,et al.  4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations , 2021, iScience.

[10]  Ivet Bahar,et al.  ProDy 2.0: increased scale and scope after 10 years of protein dynamics modelling with Python , 2021, Bioinform..

[11]  P. Mercier,et al.  Calcium binds and rigidifies the dysferlin C2A domain in a tightly coupled manner. , 2021, The Biochemical journal.

[12]  R. W. Janes,et al.  PDBMD2CD: providing predicted protein circular dichroism spectra from multiple molecular dynamics-generated protein structures , 2020, Nucleic Acids Res..

[13]  J. R. Long,et al.  Enhanced purification coupled with biophysical analyses shows cross-β structure as a core building block for Streptococcus mutans functional amyloids , 2020, Scientific Reports.

[14]  Benjamin J. Wylie,et al.  The Functional Mammalian CRES (Cystatin-Related Epididymal Spermatogenic) Amyloid is Antiparallel β-Sheet Rich and Forms a Metastable Oligomer During Assembly , 2019, Scientific Reports.

[15]  Peter A Keyel,et al.  Multiple Parameters Beyond Lipid Binding Affinity Drive Cytotoxicity of Cholesterol-Dependent Cytolysins , 2018, Toxins.

[16]  R. Salter,et al.  Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion , 2017, Front. Immunol..

[17]  D. Liebetanz,et al.  Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy , 2017, Journal of Cell Science.

[18]  P. Bhattacharjee,et al.  Intrinsic repair protects cells from pore-forming toxins by microvesicle shedding , 2017, Cell Death and Differentiation.

[19]  Alexander D. MacKerell,et al.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.

[20]  P. Mcneil,et al.  Membrane Repair: Mechanisms and Pathophysiology. , 2015, Physiological reviews.

[21]  Peter A Keyel,et al.  How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. , 2014, Cytokine.

[22]  A. Meyer,et al.  Alternate splicing of dysferlin C2A confers Ca²⁺-dependent and Ca²⁺-independent binding for membrane repair. , 2014, Structure.

[23]  G. Núñez,et al.  3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome* , 2013, The Journal of Biological Chemistry.

[24]  Simon C Watkins,et al.  Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation , 2013, The Journal of Immunology.

[25]  Robyn Roth,et al.  Reduction of Streptolysin O (SLO) Pore-Forming Activity Enhances Inflammasome Activation , 2013, Toxins.

[26]  Stavros J. Hamodrakas,et al.  A Consensus Method for the Prediction of ‘Aggregation-Prone’ Peptides in Globular Proteins , 2013, PloS one.

[27]  K. Kameyama,et al.  The C2A domain in dysferlin is important for association with MG53 (TRIM72) , 2012, PLoS currents.

[28]  Peter A Keyel,et al.  Coordinate Stimulation of Macrophages by Microparticles and TLR Ligands Induces Foam Cell Formation , 2012, The Journal of Immunology.

[29]  Simon C Watkins,et al.  Visualization of bacterial toxin induced responses using live cell fluorescence microscopy. , 2012, Journal of visualized experiments : JoVE.

[30]  A. Aderem,et al.  Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.

[31]  Peter A Keyel,et al.  Macrophage responses to bacterial toxins: a balance between activation and suppression , 2011, Immunologic research.

[32]  J. Gastier-Foster,et al.  Novel diagnostic features of dysferlinopathies , 2010, Muscle & nerve.

[33]  E. Hoffman,et al.  Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. , 2010, The American journal of pathology.

[34]  Bartek Wilczynski,et al.  Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..

[35]  C. Béroud,et al.  Analysis of the DYSF mutational spectrum in a large cohort of patients , 2009, Human mutation.

[36]  B. Cookson,et al.  Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.

[37]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[38]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[39]  Nancy N. Byl,et al.  What can we learn from animal models , 2008 .

[40]  K. Bushby,et al.  Dysferlin‐deficient muscular dystrophy features amyloidosis , 2008, Annals of neurology.

[41]  Wim Jiskoot,et al.  Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.

[42]  H. Schulz,et al.  Dysfunction of dysferlin-deficient hearts , 2007, Journal of Molecular Medicine.

[43]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[44]  K. Campbell,et al.  Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. , 2007, The Journal of clinical investigation.

[45]  Richard T. Lee,et al.  Torn apart: membrane rupture in muscular dystrophies and associated cardiomyopathies. , 2007, The Journal of clinical investigation.

[46]  Robert H. Brown,et al.  Dysferlin in Membrane Trafficking and Patch Repair , 2007, Traffic.

[47]  J. T. Dunnen,et al.  AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  C. Paradas,et al.  Dysferlin expression in monocytes: A source of mRNA for mutation analysis , 2007, Neuromuscular Disorders.

[49]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[50]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[51]  J. Meldolesi,et al.  Enlargeosome, an exocytic vesicle resistant to nonionic detergents, undergoes endocytosis via a nonacidic route. , 2004, Molecular biology of the cell.

[52]  K. Campbell,et al.  Dysferlin and the plasma membrane repair in muscular dystrophy. , 2004, Trends in cell biology.

[53]  P. Mcneil,et al.  Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.

[54]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.

[55]  J. Dubochet,et al.  Conversion of a transmembrane to a water-soluble protein complex by a single point mutation , 2002, Nature Structural Biology.

[56]  D. Davis,et al.  Calcium-sensitive Phospholipid Binding Properties of Normal and Mutant Ferlin C2 Domains* , 2002, The Journal of Biological Chemistry.

[57]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[58]  V. Sukhorukov,et al.  Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy , 2000, Neurology.

[59]  T. Südhof,et al.  Solution structures of the Ca2+-free and Ca2+-bound C2A domain of synaptotagmin I: does Ca2+ induce a conformational change? , 1998, Biochemistry.

[60]  H. M. Fishman,et al.  Endocytotic Formation of Vesicles and Other Membranous Structures Induced by Ca2+ and Axolemmal Injury , 1998, The Journal of Neuroscience.

[61]  N. A. Rodionova,et al.  Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe , 1991, Biopolymers.

[62]  M. Hosokawa,et al.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.

[63]  L. Serpell,et al.  X-ray fiber diffraction of amyloid fibrils. , 1999, Methods in enzymology.

[64]  P. Mcneil,et al.  Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.